Aging and declining testosterone past, present, and hopes for the future

Barry R Zirkin, Joyce Lisa Tenover

Research output: Contribution to journalArticle

Abstract

As men age, serum testosterone (T) levels decline, whereas serum luteinizing hormone (LH) levels increase somewhat or remain unchanged. Age-related reductions in T levels may be associated with alterations in body composition; energy level; muscle strength; physical, sexual, and cognitive functions; and mood. The predominant contributor to the decline in serum T levels is the decreased ability of the aging testes to make T. As in humans, the Brown Norway rat demonstrates age-related reductions in serum T levels in the setting of unchanged or modestly increased serum LH levels. In this rat model, the ability of aged Leydig cells, the terminally differentiated T-producing cells of the testis, to produce T in response to LH stimulation is significantly diminished. This review begins with a discussion of what is known of the molecular mechanisms by which T synthesis declines with Leydig cell aging. It concludes with a brief history of T replacement therapy, current guidelines, controversies related to T replacement therapy in older men, and proposed future clinical directions.

Original languageEnglish (US)
Pages (from-to)1111-1118
Number of pages8
JournalJournal of Andrology
Volume33
Issue number6
DOIs
StatePublished - 2012

Fingerprint

Hope
Testosterone
Luteinizing Hormone
Serum
Aptitude
Leydig Cells
Testis
Cell Aging
Muscle Strength
Body Composition
Cognition
Guidelines
Therapeutics

Keywords

  • Hypogonadism
  • Leydig cells

ASJC Scopus subject areas

  • Urology
  • Reproductive Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Aging and declining testosterone past, present, and hopes for the future. / Zirkin, Barry R; Tenover, Joyce Lisa.

In: Journal of Andrology, Vol. 33, No. 6, 2012, p. 1111-1118.

Research output: Contribution to journalArticle

@article{dcd94cfd450e44808152bcb4f66c5141,
title = "Aging and declining testosterone past, present, and hopes for the future",
abstract = "As men age, serum testosterone (T) levels decline, whereas serum luteinizing hormone (LH) levels increase somewhat or remain unchanged. Age-related reductions in T levels may be associated with alterations in body composition; energy level; muscle strength; physical, sexual, and cognitive functions; and mood. The predominant contributor to the decline in serum T levels is the decreased ability of the aging testes to make T. As in humans, the Brown Norway rat demonstrates age-related reductions in serum T levels in the setting of unchanged or modestly increased serum LH levels. In this rat model, the ability of aged Leydig cells, the terminally differentiated T-producing cells of the testis, to produce T in response to LH stimulation is significantly diminished. This review begins with a discussion of what is known of the molecular mechanisms by which T synthesis declines with Leydig cell aging. It concludes with a brief history of T replacement therapy, current guidelines, controversies related to T replacement therapy in older men, and proposed future clinical directions.",
keywords = "Hypogonadism, Leydig cells",
author = "Zirkin, {Barry R} and Tenover, {Joyce Lisa}",
year = "2012",
doi = "10.2164/jandrol.112.017160",
language = "English (US)",
volume = "33",
pages = "1111--1118",
journal = "Journal of Andrology",
issn = "0196-3635",
publisher = "American Society of Andrology Inc.",
number = "6",

}

TY - JOUR

T1 - Aging and declining testosterone past, present, and hopes for the future

AU - Zirkin, Barry R

AU - Tenover, Joyce Lisa

PY - 2012

Y1 - 2012

N2 - As men age, serum testosterone (T) levels decline, whereas serum luteinizing hormone (LH) levels increase somewhat or remain unchanged. Age-related reductions in T levels may be associated with alterations in body composition; energy level; muscle strength; physical, sexual, and cognitive functions; and mood. The predominant contributor to the decline in serum T levels is the decreased ability of the aging testes to make T. As in humans, the Brown Norway rat demonstrates age-related reductions in serum T levels in the setting of unchanged or modestly increased serum LH levels. In this rat model, the ability of aged Leydig cells, the terminally differentiated T-producing cells of the testis, to produce T in response to LH stimulation is significantly diminished. This review begins with a discussion of what is known of the molecular mechanisms by which T synthesis declines with Leydig cell aging. It concludes with a brief history of T replacement therapy, current guidelines, controversies related to T replacement therapy in older men, and proposed future clinical directions.

AB - As men age, serum testosterone (T) levels decline, whereas serum luteinizing hormone (LH) levels increase somewhat or remain unchanged. Age-related reductions in T levels may be associated with alterations in body composition; energy level; muscle strength; physical, sexual, and cognitive functions; and mood. The predominant contributor to the decline in serum T levels is the decreased ability of the aging testes to make T. As in humans, the Brown Norway rat demonstrates age-related reductions in serum T levels in the setting of unchanged or modestly increased serum LH levels. In this rat model, the ability of aged Leydig cells, the terminally differentiated T-producing cells of the testis, to produce T in response to LH stimulation is significantly diminished. This review begins with a discussion of what is known of the molecular mechanisms by which T synthesis declines with Leydig cell aging. It concludes with a brief history of T replacement therapy, current guidelines, controversies related to T replacement therapy in older men, and proposed future clinical directions.

KW - Hypogonadism

KW - Leydig cells

UR - http://www.scopus.com/inward/record.url?scp=84874435070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874435070&partnerID=8YFLogxK

U2 - 10.2164/jandrol.112.017160

DO - 10.2164/jandrol.112.017160

M3 - Article

C2 - 22879528

AN - SCOPUS:84874435070

VL - 33

SP - 1111

EP - 1118

JO - Journal of Andrology

JF - Journal of Andrology

SN - 0196-3635

IS - 6

ER -